Le 127e Congrès de la SFO aura lieu du 8 au 10 mai 2021 en version digitale.

Détails d’accès

https://sfo.e-congres.com/

Consulter le programme définitif du Congrès SFO 2021

Orbis Canada presents its first Speaker Series.

Topic: Changing the Way the World Sees

Date: Thursday, May 27, 2021

Time: 7:30pm–9:00pm EST

Special guests:
– Dr. Simon Holland, MD (the University of British Columbia, Chair of Orbis Canada)
– Dr. Hunter Cherwek, MD (Vice President, Clinical Services & Technology, Orbis International)
– Lisa McKeen (CEO, Orbis Canada)

Learning Objectives:

In Orbis Canada’s first Speaker Series, you will learn about the mission and work of Orbis, and our role as a global leader and innovator in the fight against avoidable blindness. You will learn about opportunities to get involved with Orbis at various stages of your training (students, residents, practicing ophthalmologists). You’ll learn about Orbis Canada’s role as an affiliate of Orbis International. Finally, you’ll learn how our focus on technology and innovation has allowed us to continue to thrive during the COVID-19 pandemic. There will be a Q&A session with our panelists.

Access Details:
Event page and FREE registration at:
orbiscan.akaraisin.com/ui/FutureVisionLeaders/upcoming-events

Please note that to register for the event, you must be an Orbis Future Vision Leaders member. Becoming a member is quick, easy, and entirely free – register here.

Membership is available to all ophthalmology residents, medical students, and university graduates.

Date: Friday April 23, 2021

Time: 9:00 AM – 10:30 AM EST

Topic: Childhood glaucoma’s  

Speaker: Dr. Asim Ali 

Registration:

Zoom Link – https://us02web.zoom.us/j/83510355878?pwd=c0J0S2pTTUpGTnNDdWJVVkRzYmNuUT09

Passcode: X6DFb8

The next session of the Cornea Surgical Video Learning Series, co-moderated by Professor Sadeer Hannush (Wills Eye Hospital) and Professor Allan Slomovic (University of Toronto) and their respective Cornea Departments will be hosted on the following date:

Date: Thursday May 20th 2021
Time: 7:30 – 9pm EST

Keynote Lecture: “Implanting & Securing Posterior Chamber IOLs without Capsular Support using the Canabrava 4-Flanged Technique”- Dr Sergio Canabrava

Title: Implanting & Securing Posterior Chamber IOLs without Capsular Support using the Canabrava 4-Flanged Technique

Case Presentations:

1. Gore-tex Sutured PCIOL Gone Bad – Dr Ashley Khalili
2. Fixating IOL-Bag complex with the 4-flange technique – Dr Eyal Cohen
3. Repair of traumatic iris dialysis and complex phacoemulsification – Dr Michael Mimouni

Accreditation

CPD points are available for attending these rounds as per the Royal College.

Access details:

Register in advance for this webinar here.
https://us02web.zoom.us/webinar/register/WN_bQyvcofMQk21gj0xmzV2Nw
After registering, you will receive a confirmation email containing information about joining the webinar.

This session will be recorded and placed online for future viewing. Past sessions may be accessed here also.

Join the online FREE Choosing Wisely Canada National Meeting in collaboration with the Canadian Medical Association.

Date: May 12 and 13, 2021

This year’s National Meeting will explore the interplay between overuse and underuse, and how to prevent low-value services from diverting energy and resources from care that truly matters during these precarious times.

Bringing together health professionals, patients, system leaders, and researchers, this two-day virtual event is a unique opportunity to learn about leading Choosing Wisely efforts taking place across the country.

At the National Meeting you will:

• Engage with the Choosing Wisely community in an energized exchange of ideas on overuse
• Hear about practical and implementable strategies for reducing overuse, and understand their impact
• Network with colleagues who share a commitment to reducing overuse

Learning Objectives

• Translate and apply best practices for reducing overuse in health care in their clinical settings
• Design effective approaches for evaluating interventions related to reducing overuse
• Develop strategies to share successful interventions across their health care organization

Accreditation

• ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA:
  This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Ottawa’s Office of Continuing Professional Development. You may claim a maximum of 8.25 hours (credits are automatically calculated).
• COLLEGE OF FAMILY PHYSICIANS OF CANADA:
  This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the University of Ottawa’s Office of Continuing Professional Development for up to 8.25 Mainpro+ credits.

Access details

All content included in the National Meeting will be presented free of charge. Register here.

avril 2021

RÉSUMÉ ANALYTIQUE

Le présent rapport fait le survol des démarches factuelles dans le téléglaucome (TG) utilisées au Canada en date de janvier 2021. Le TG consiste en un ensemble d’options qui ont recours à la télémédecine pour améliorer les soins prodigués aux patients présentant un glaucome (qu’il s’agisse de patients qui ont déjà reçu leur diagnostic ou qui sont exposés à un risque de glaucome). Ce document se veut un tremplin pour les ophtalmologistes du Canada qui souhaitent se lancer dans le TG.

Ce projet est le fruit des réflexions du Groupe de travail sur le téléglaucome de la Société canadienne de glaucome, qui est formé de spécialistes du glaucome et d’ophtalmologistes généralistes de partout au pays.

Depuis l’arrivée de la pandémie de COVID-19, nombreux sont les médecins qui se sont tournés vers les soins virtuels, ne serait-ce que partiellement. Trois axes justifient le recours général au TG. D’abord, on s’attend à ce que la demande en matière de soins ophtalmologiques au Canada augmente en raison du vieillissement de notre population et de la prévalence croissante des pathologies menaçant le pronostic visuel, comme le glaucome, la dégénérescence maculaire liée à l’âge et les cataractes. Or, l’amélioration de l’accès à ces services demeure un enjeu de taille dans un contexte de budgets réduits et d’un nombre limité de prestataires de soins. Ensuite, les populations rurales et éloignées sont depuis longtemps moins bien desservies en matière de soins spécialisés, et leur santé en souffre. En effet, l’équité en santé est au centre des préoccupations des politiques sanitaires canadiennes depuis des décennies, mais les progrès ne sont pas à la hauteur des attentes. Enfin, tant les patients que les prestataires de soins affichent une préférence marquée envers les soins virtuels parce qu’ils offrent des économies de temps et d’argent. Les soins virtuels représentent une solution réaliste pour répondre aux besoins de notre population en matière de santé, tout en permettant au système de santé de tirer la meilleure partie de ressources restreintes.

On trouvera, dans les pages qui suivent, les grandes lignes de trois modèles de TG accompagnés de cas cliniques de même qu’une proposition de configuration standardisée en vue du TG. Ces modèles – le module d’extension, le modèle à intégration numérique ou intra-cabinet et le modèle de collaboration12 – décrivent comment les médecins peuvent, de façon virtuelle, réaliser des dépistages (y compris le triage), faire des consultations et assurer la surveillance de leurs patients. Les médecins peuvent souhaiter ajouter l’un ou l’autre des éléments de ces modèles à leur pratique professionnelle, selon leur situation propre. Ce rapport admet également l’existence d’une lacune importante du TG, soit l’absence de gonioscopie. Les médecins doivent donc trouver des solutions de rechange pour évaluer le risque de glaucome à angle fermé.

Le lecteur trouvera également dans ce rapport des suggestions de schémas de pratique professionnelle, des outils pour réaliser les évaluations à distance, un résumé des enjeux médicolégaux et des aspects propres au permis d’exercice et à l’innocuité (y compris de manquer le diagnostic du glaucome à angle fermé et d’autres glaucomes secondaires), une synthèse des avantages et des défis du TG (notamment en ce qui a trait à la facturation), une réflexion sur l’avenir prometteur du TG ainsi que des recommandations sur la façon de surmonter les obstacles en vue d’optimiser les soins offerts dans un contexte virtuel.

La pandémie de COVID-19 nous a fait voir que les limites des soins virtuels sont en grande partie celles que nous leur attribuons. La progression des soins virtuels doit essentiellement trouver son élan de l’intérieur même du système de santé. Nous espérons que ce document outillera et inspirera les médecins à forger leur propre chemin dans la téléophtalmologie dans son ensemble, et dans le TG en particulier.

Lisez le rapport complet ici.

April 2021

EXECUTIVE SUMMARY

This report provides a review of evidence-informed approaches to teleglaucoma (TG) care in Canadian contexts as of January 2021. TG is defined as a spectrum of options that adapts telemedicine approaches to enhance care for glaucoma patients (those diagnosed with as well as at risk for developing glaucoma). The objective of this document is to act as a foundation for Canadian ophthalmologists who wish to establish their own TG practice.

This work was undertaken by the Canadian Glaucoma Society Teleglaucoma Working Group, comprised of glaucoma specialists and comprehensive ophthalmologists from across the country.

Many physicians have transitioned to a partially virtual care paradigm since the onset of COVID-19. The rationale for widespread adoption of TG is three-fold. First, the demand for ophthalmic services in Canada is projected to increase with our ageing population and rising prevalence of sight-threatening conditions such as glaucoma, age-related macular degeneration, and cataract. Enhancing access to these services with a limited budget and supply of providers remains critically unresolved. Second, rural and remote communities continue to grapple with underservicing for specialist care, leading to poorer health outcomes. For many decades, health equity has been a central focus of Canadian health policy with limited progress. Third, there is a strong patient and provider preference for virtual care as it is more time- and cost-effective. Virtual care offers a feasible solution to meet the health needs of our population while allowing our health systems to optimally utilize finite resources.

This report outlines three models of care in TG with sample case scenarios and offers a template for a standardized TG setup. The models of care elaborated upon include modular extension, in-office, and collaborative.12 These models describe how clinicians can accomplish virtual screening (including triage), consultation and monitoring of patients. Clinicians may wish to incorporate one or more elements of these models into their practice depending on their own situational context. This report also acknowledges an important gap in TG, which is the absence of gonioscopy. Clinicians should consider alternative methods to evaluate the risk of angle closure glaucoma.

This report also offers suggestions for practice patterns, outlines tools for remote assessment, summarizes licensure, medicolegal and safety considerations (including missing angle closure and other secondary glaucomas), reviews merits and challenges of TG (including the billing landscape), considers the promising future of TG, and offers suggestions on how to overcome barriers in order to optimize care for patients in the virtual environment.

COVID-19 has illuminated the ways in which limitations to virtual care have been largely self-imposed. Much of our advocacy in advancing virtual care must occur at the health systems level. We hope that this document can equip providers with the knowledge and inspiration to carve their own path in the realm of teleglaucoma and teleophthalmology at-large.

Read the full report here.

April 2021

Since it began, the COVID-19 pandemic has been a highly dynamic situation. New developments in the pandemic have led to new evidence, which, in turn, have informed new or refined public health guidance.

As you may know, Canadian public health guidance around the AstraZeneca COVID-19 vaccine has evolved in recent weeks, in part due to concerns around vaccine-induced immune thrombotic thrombocytopenia (VITT, also known as vaccine-induced prothrombotic immune thrombocytopenia/VIPIT), which has been reported following post-licensure use of the vaccine in several countries.

The Public Health Agency of Canada is committed to addressing the evolving COVID-19 vaccine-related knowledge and training needs of health care providers. We will continue to offer webinars, and other training opportunities, to health care providers, to share the latest evidence and guidance with you on authorized COVID-19 vaccines, vaccine safety and related topics.

In the meantime, The Public Health Agency of Canada has prepared a short information bulletin on AstraZeneca and VITT .

Access Details

Read the complete PHAC VITT infobulletin here.

The bulletin compiles statements and guidance documents on these topics from a number of federal and provincial sources.

If you have any questions or comments, please share them through email at [email protected].

The April 2021 CJO is now available online. Here are just a few of this issue’s highlights:  

Resident Perspectives + visual abstract: Our residents have summarized 4 articles that are relevant to ophthalmology learners here in Canada and around the globe, including the article featured in our April visual abstract, Impact of the COVID-19 pandemic on characteristics of retinal detachments: the Canadian experience.  

Original research articles:

• Micro-incision, trans-iridal aspiration cutter biopsy for ciliary body tumours [original research]
• Age-related differences in presentation and outcomes of anti-VEGF treatment of retinal vein occlusion  [original research]
• Optical coherence tomography angiography findings in patients with COVID-19  [original research]
• Outcomes and complications of Boston keratoprosthesis type I implantation in unilateral versus bilateral corneal blindness [original research]
• Use of neuromuscular blocking drugs in strabismus surgery: systematic review and ophthalmology survey study [systematic review]

Research letters, photo essays, and case reports:

• Distribution of recurrence time intervals after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization [research letter]
• Canadian ophthalmology resident experience during the COVID-19 pandemic [case report]
• Serous retinal detachment following bronchoscopy-induced hypertensive emergency [case report]
• Late-onset spontaneous EX-PRESS shunt dislocation into anterior chamber [case report]
• Retinal ganglion cell loss in postmortem tissue of Alzheimer disease, glaucoma, and healthy normal subjects [case report]

Follow the CJO on social media:

• Twitter: @CanJOphth
• Instagram: @cjo_jco
• Facebook: CanJOphth